Syndetics cover image
Image from Syndetics

Antibiotics and Urinary Tract Infections

By: Contributor(s): Material type: ArticlePublication details: MDPI - Multidisciplinary Digital Publishing Institute 2015Description: 1 electronic resource (X, 143 p.)Content type:
  • text
Media type:
  • computer
Carrier type:
  • online resource
ISBN:
  • 9783906980799
  • 9783906980805
Subject(s): Online resources: Summary: Urinary tract infections (UTI) are one of the most frequently occurring infections, not only community acquired, but also hospital acquired infections. An increase of resistant uropathogens against commonly used antibiotics can be observed worldwide, a subject of great concern. Several strategies are discussed how to cope with this problem: i) not to use antibiotics, when not indicated, e.g. asymptomatic bacteriuria, or when non-antimicrobial measures are available, e.g. for prophylaxis of recurrent UTI; ii) to prefer even old antibiotics, which still have preserved their antibacterial activity against uropathogens; iii) if broad spectrum antibiotics are needed for empiric therapy of severe infections, to use the right and high enough dosages to reduce selection of resistant pathogens, and to step down to a more tailored antibiotic therapy as soon as possible; iv) to control and try to avoid health care associated UTI by optimal hygienic and interventional strategies; and last but not least v) to stimulate development of new antibiotics, especially when new bacterial targets can be approached
No physical items for this record

Open Access Unrestricted online access star

Urinary tract infections (UTI) are one of the most frequently occurring infections, not only community acquired, but also hospital acquired infections. An increase of resistant uropathogens against commonly used antibiotics can be observed worldwide, a subject of great concern. Several strategies are discussed how to cope with this problem: i) not to use antibiotics, when not indicated, e.g. asymptomatic bacteriuria, or when non-antimicrobial measures are available, e.g. for prophylaxis of recurrent UTI; ii) to prefer even old antibiotics, which still have preserved their antibacterial activity against uropathogens; iii) if broad spectrum antibiotics are needed for empiric therapy of severe infections, to use the right and high enough dosages to reduce selection of resistant pathogens, and to step down to a more tailored antibiotic therapy as soon as possible; iv) to control and try to avoid health care associated UTI by optimal hygienic and interventional strategies; and last but not least v) to stimulate development of new antibiotics, especially when new bacterial targets can be approached

Creative Commons Licence cc by cc https://creativecommons.org/licenses/by/4.0/

eng

Freely available e-book